Send mail to Author

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _     _____              __   __    _  __     ___    
| || | ||  |  ___||     ___    \ \\/ //  | |/ //   / _ \\  
| '--' ||  | ||__      /   ||   \ ` //   | ' //   | / \ || 
| .--. ||  | ||__     | [] ||    | ||    | . \\   | \_/ || 
|_|| |_||  |_____||    \__ ||    |_||    |_|\_\\   \___//  
`-`  `-`   `-----`      -|_||    `-`'    `-` --`   `---`   
                         `-`
 


Back to frontdoor view

OPUS4 Logo